A base substitution in the promoter associated with the human haptoglobin 2-1 modified phenotype decreases transcriptional activity and responsiveness to interleukin-6 in human hepatoma cells

Am J Hum Genet. 1993 May;52(5):974-80.

Abstract

An A-to-C base substitution at nucleotide position -61 in the promoter region of the human haptoglobin gene (Hp) has been shown to be strongly associated with the haptoglobin 2-1 modified (Hp2-1mod) phenotype. In order to investigate whether this base substitution is the cause of reduced expression of the Hp2 allele relative to the Hp1 allele in individuals with the Hp2-1mod phenotype, we used the chloramphenicol acetyl transferase (CAT) expression system to evaluate promoter function. In HepG2 cells, which normally express their endogenous haptoglobin genes, CAT plasmid constructs with the -61C base change in the promoter had about 10-fold-lower transcriptional activity after transfection than did the Hp control construct. The -61C substitution also rendered the construct unresponsive to treatment by interleukin-6 after transfection into Hep3B2 cells, which normally do not express haptoglobin but do so in response to stimulation by acute-phase reactants. In addition, two base substitutions, T to A and A to G, at positions -104 and -55G, respectively, in the promoter region of the Hp1 allele, are also associated with the Hp2-1mod phenotype. CAT constructs with both substitutions (-104A-55G) and with one substitution (-55G) showed activity similar to that in the Hp control when transfected into both HepG2 and Hep3B2 cells, although interleukin-6 induction was less than with the Hp control construct. These results further support the hypothesis that the Hp2-1mod phenotype results, in part, from the -61C mutation in the promoter region of the Hp2 gene.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles
  • Carcinoma, Hepatocellular / genetics
  • Chloramphenicol O-Acetyltransferase / metabolism
  • Haptoglobins / drug effects
  • Haptoglobins / genetics*
  • Haptoglobins / physiology
  • Humans
  • Interleukin-6 / pharmacology*
  • Liver Neoplasms / genetics
  • Phenotype
  • Plasmids
  • Point Mutation*
  • Promoter Regions, Genetic / drug effects
  • Recombinant Proteins / pharmacology
  • Transcription, Genetic*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Haptoglobins
  • Interleukin-6
  • Recombinant Proteins
  • Chloramphenicol O-Acetyltransferase